Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS

Validation of Actionable Genomic ABerrations in a paediatric Oncology Network for Doctorate students

CORDIS fournit des liens vers les livrables publics et les publications des projets HORIZON.

Les liens vers les livrables et les publications des projets du 7e PC, ainsi que les liens vers certains types de résultats spécifiques tels que les jeux de données et les logiciels, sont récupérés dynamiquement sur OpenAIRE .

Livrables

Annual report 2 on exploitation, dissemination and outreach (s’ouvre dans une nouvelle fenêtre)

Annual report 2 on exploitation dissemination and outreach activities

Manuscript on validation of epigenetic drug targets in rhabdomyosarcoma (s’ouvre dans une nouvelle fenêtre)

The manuscript itself will have to remain confidential until it is published or shared on bioRxiv, but the deliverable is achieved in the form of a report (on this manuscript). That report can be made public if it does not contain any sensitive information.

Manuscript on novel targets of Ewing sarcoma EMT (s’ouvre dans une nouvelle fenêtre)

A manuscript on novel targets of Ewing sarcoma EMT will at least be drafted, aiming to eventually be published in a peer-reviewed journal.The manuscript itself will have to remain confidential until it is published, but the deliverable is achieved in the form of a report (on this manuscript). That report can be made public if it does not contain any sensitive information.

Manuscript describing (i) the landscape of the surfaceome in Medullo, (ii) from this data: functional validation of a novel target (s’ouvre dans une nouvelle fenêtre)

The manuscript itself will have to remain confidential until it is published or shared on bioRxiv, but the deliverable is achieved in the form of a report (on this manuscript). That report can be made public if it does not contain any sensitive information.

Manuscript on in vitro testing of gdTcells in paediatric cancer (s’ouvre dans une nouvelle fenêtre)

The manuscript itself will have to remain confidential until it is published or shared on bioRxiv, but the deliverable is achieved in the form of a report (on this manuscript). That report can be made public if it does not contain any sensitive information.

Annual report 3 on exploitation, dissemination and outreach (s’ouvre dans une nouvelle fenêtre)

Annual report 3 on exploitation, dissemination and outreach activities

Annual report 1 on exploitation, dissemination and outreach (s’ouvre dans une nouvelle fenêtre)

Annual report 1 on exploitation dissemination and outreach activities

Manuscript on evidence-based recommendation for efficacious precision medicine/ conventional chemotherapeutic drug combinations in drug development programs for children with leukemia (s’ouvre dans une nouvelle fenêtre)

The manuscript itself will have to remain confidential until it is published or shared on bioRxiv, but the deliverable is achieved in the form of a report (on this manuscript). That report can be made public if it does not contain any sensitive information.

Manuscript on validation of one targeted immune intervention based on in silico and in vitro analysis (s’ouvre dans une nouvelle fenêtre)

The manuscript itself will have to remain confidential until it is published or shared on bioRxiv, but the deliverable is achieved in the form of a report (on this manuscript). That report can be made public if it does not contain any sensitive information.

Manuscript on role of chromatin remodeling in neuroblastoma (s’ouvre dans une nouvelle fenêtre)

The manuscript itself will have to remain confidential until it is published or shared on bioRxiv, but the deliverable is achieved in the form of a report (on this manuscript). That report can be made public if it does not contain any sensitive information.

Annual report 4 on exploitation, dissemination and outreach (s’ouvre dans une nouvelle fenêtre)

Annual report 4 on exploitation, dissemination and outreach activities

Manuscript on epigenetic processes driving SMARCB1 /SMARCB4 deficient paediatric tumours (s’ouvre dans une nouvelle fenêtre)

The manuscript itself will have to remain confidential until it is published or shared on bioRxiv, but the deliverable is achieved in the form of a report (on this manuscript). That report can be made public if it does not contain any sensitive information.

Manuscript on the diagnostic/prognostic value of exosome-associated miRNAs in sarcomas (s’ouvre dans une nouvelle fenêtre)

The manuscript itself will have to remain confidential until it is published or shared on bioRxiv, but the deliverable is achieved in the form of a report (on this manuscript). That report can be made public if it does not contain any sensitive information.

Publications

Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma (s’ouvre dans une nouvelle fenêtre)

Auteurs: Salih Demir, Negin Razizadeh, Emilie Indersie, Sophie Branchereau, Stefano Cairo, Roland Kappler
Publié dans: Hepatology Communications, Numéro 8, 2024, ISSN 2471-254X
Éditeur: Hepatology Communications
DOI: 10.1097/hc9.0000000000000378

Evaluating Circulating Biomarkers for Diagnosis, Prognosis, and Tumor Monitoring in Pediatric Sarcomas: Recent Advances and Future Directions (s’ouvre dans une nouvelle fenêtre)

Auteurs: Joaquín J. Maqueda, Alessandra De Feo, Katia Scotlandi
Publié dans: Biomolecules, Numéro 14, 2025, Page(s) 1306, ISSN 2218-273X
Éditeur: Cancers
DOI: 10.3390/biom14101306

CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles (s’ouvre dans une nouvelle fenêtre)

Auteurs: Alessandra De Feo, Marcello Manfredi, Caterina Mancarella, Joaquín J. Maqueda, Veronica De Giorgis, Ymera Pignochino, Marika Sciandra, Camilla Cristalli, Massimo Donadelli, Katia Scotlandi
Publié dans: International Journal of Molecular Sciences, Numéro 25, 2024, Page(s) 1588, ISSN 1422-0067
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms25031588

Targeted AURKA degradation: Towards new therapeutic agents for neuroblastoma (s’ouvre dans une nouvelle fenêtre)

Auteurs: Muhammad Rishfi, Simon Krols, Fien Martens, Sarah-Lee Bekaert, Ellen Sanders, Aline Eggermont, Fanny De Vloed, Joshua Robert Goulding, Martijn Risseeuw, Jan Molenaar, Bram De Wilde, Serge Van Calenbergh, Kaat Durinck
Publié dans: European Journal of Medicinal Chemistry, Numéro 247, 2023, Page(s) 115033, ISSN 0223-5234
Éditeur: Elsevier BV
DOI: 10.1016/j.ejmech.2022.115033

Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy (s’ouvre dans une nouvelle fenêtre)

Auteurs: Judith Wienke, Lindy L. Visser, Waleed M. Kholosy, Kaylee M. Keller, Marta Barisa, Evon Poon, Sophie Munnings-Tomes, Courtney Himsworth, Elizabeth Calton, Ana Rodriguez, Ronald Bernardi, Femke van den Ham, Sander R. van Hooff, Yvette A.H. Matser, Michelle L. Tas, Karin P.S. Langenberg, Philip Lijnzaad, Anne L. Borst, Elisa Zappa, Francisca J. Bergsma, Josephine G.M. Strijker, Bronte M. Verhoeven,
Publié dans: Cancer Cell, 2024, ISSN 1535-6108
Éditeur: Cell Press
DOI: 10.1016/j.ccell.2023.12.008

Adoptive cell therapy in paediatric extracranial solid tumours: current approaches and future challenges (s’ouvre dans une nouvelle fenêtre)

Auteurs: Elisa Zappa, Alice Vitali, Kathleen Anders, Jan J. Molenaar, Judith Wienke, Annette Künkele
Publié dans: European Journal of Cancer, Numéro 194, 2024, Page(s) 113347, ISSN 0959-8049
Éditeur: Pergamon Press Ltd.
DOI: 10.1016/j.ejca.2023.113347

Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving <i>ALK</i>-Targeted Therapy (s’ouvre dans une nouvelle fenêtre)

Auteurs: Charles Bobin, Yasmine Iddir, Charlotte Butterworth, Julien Masliah-Planchon, Alexandra Saint-Charles, Angela Bellini, Jaydutt Bhalshankar, Gaelle Pierron, Valérie Combaret, Valéry Attignon, Nicolas André, Nadège Corradini, Benoit Dumont, Ludovic Mansuy, Camille Khanfar, Sebastien Klein, Claire Briandet, Dominique Plantaz, Frederic Millot, Sandrine Thouvenin, Isabelle Aerts, Lee Aymar Ndounga-
Publié dans: Clinical Cancer Research, Numéro 30, 2024, Page(s) 3316-3328, ISSN 1078-0432
Éditeur: American Association for Cancer Research
DOI: 10.1158/1078-0432.ccr-24-0753

Cancer-specific epigenome identifies oncogenic hijacking by nuclear factor I family proteins for medulloblastoma progression (s’ouvre dans une nouvelle fenêtre)

Auteurs: Ryo Shiraishi, Gabriele Cancila, Kohei Kumegawa, Jacob Torrejon, Irene Basili, Flavia Bernardi, Patricia Benites Goncalves da Silva, Wanchen Wang, Owen Chapman, Liying Yang, Maki Jami, Kayo Nishitani, Yukimi Arai, Zhize Xiao, Hua Yu, Valentina Lo Re, Véronique Marsaud, Julie Talbot, Bérangère Lombard, Damarys Loew, Maho Jingu, Konstantin Okonechnikov, Masaki Sone, Norio Motohashi, Yoshitsugu Ao
Publié dans: Developmental Cell, Numéro 59, 2024, Page(s) 2302-2319.e12, ISSN 1534-5807
Éditeur: Cell Press
DOI: 10.1016/j.devcel.2024.05.013

Three-Dimensional Modeling of Solid Tumors and Their Microenvironment to Evaluate T Cell Therapy Efficacy In Vitro (s’ouvre dans une nouvelle fenêtre)

Auteurs: Ronja Pscheid, Esther Drent, Judith Wienke, Josephine G. M. Strijker, Mark Throsby, Jan J. Molenaar
Publié dans: The Journal of Immunology, Numéro 211, 2025, Page(s) 229-240, ISSN 0022-1767
Éditeur: American Association of Immunologists
DOI: 10.4049/jimmunol.2200573

Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function (s’ouvre dans une nouvelle fenêtre)

Auteurs: Marta Barisa, Elisa Zappa, Henrike Muller, Rivani Shah, Juliane Buhl, Benjamin Draper, Courtney Himsworth, Chantelle Bowers, Sophie Munnings-Tomes, Marilena Nicolaidou, Sonia Morlando, Katie Birley, Clara Leboreiro-Babe, Alice Vitali, Laura Privitera, Kyle O’Sullivan, Ailsa Greppi, Magdalena Buschhaus, Mario Barrera Román, Sam de Blank, Femke van den Ham, Brenna R. van ‘t Veld, Gabrielle Ferr
Publié dans: 2024
Éditeur: Cold Spring Harbor Laboratory
DOI: 10.1101/2024.02.19.580939

YAP1 is a key regulator of EWS::FLI1-dependent malignant transformation upon IGF-1 mediated reprogramming of bone mesenchymal stem cells (s’ouvre dans une nouvelle fenêtre)

Auteurs: Rahil Noorizadeh, Barbara Sax, Tahereh Javaheri, Branka Radic Sarikas, Valerie Fock, Maximilian Kauer, Aleksandr Bykov, Veveeyan Suresh, Michaela Schlederer, Lukas Kenner, Gerhard Weber, Wolfgang Mikulits, Florian Halbritter, Richard Moriggl, Heinrich Kovar
Publié dans: 2024
Éditeur: Cold Spring Harbor Laboratory
DOI: 10.1101/2024.07.15.603565

Recherche de données OpenAIRE...

Une erreur s’est produite lors de la recherche de données OpenAIRE

Aucun résultat disponible

Mon livret 0 0